Samsung Biologics debuted last week in Seoul with the largest IPO in South Korea in years, according to the Associated Press.
During the company's third quarter earnings call, CEO Mark Casper highlighted a number of recent clinical and diagnostic product launches and initiatives.
New York University has been awarded
Title: Assay plates, reader systems and methods for luminescence test measurements.
Patent Number: 8,808,627
Filed: Nov. 11, 2010
Siemens has been awarded
The Regents of the University of California have been awarded
Samsung has been awarded
Roche has been awarded
Samsung has been awarded US Patent No. 8,618,253, "Modified RNAse H and detection of nucleic acid amplification."
Win Den Chung and Jason Opdyke are named as inventors.
Bio-Rad Laboratories has been awarded US Patent No. 8,560,247, "Multi-stage, regression-based PCR analysis system."
Jeffrey Lerner is named as the inventor.
Russian CRISPR researcher moves along with plans to ultimately alter the genes of embryos of deaf couples, though awaits regulatory approval, Nature News reports.
University of California, San Francisco, researchers have uncovered a gene mutations that appears to make a father-son duo more efficient sleepers.
NPR reports a large health insurer has begun to cover some pharmacogenetic tests for psychiatric drugs.
In PLOS this week: genome-wide association study of non-syndromic orofacial cleft subtypes, epigenetic and transcriptomic analysis of pancreatic ductal adenocarcinoma, and more.